Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

554
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
554
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

274
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
274
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

248
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
248
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

530
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
530
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

326
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
326
Relative Risk01:12

Relative Risk

2.1K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same author

Learning association from multiple intermediate events for dynamic prediction of survival: an application to cardiovascular disease prognosis.

Biometrics·2026
Same author

A double-semiparametric approach for extending mixture cure models with interval-censored data.

Statistical methods in medical research·2026
Same author

Regression analysis of interval-censored competing risks data with missing causes of failure: A direct likelihood approach.

Statistical methods in medical research·2026
Same author

Estimating Conditional Complier Quantile Treatment Effect via Stratified Quantile Regression.

Statistics in medicine·2026
Same author

Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.

BMJ (Clinical research ed.)·2026
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Frailty modelling approaches for semi-competing risks data.

Il Do Ha1, Liming Xiang2, Mengjiao Peng2

  • 1Department of Statistics, Pukyong National University, Busan, 608-737, South Korea. idha1353@pknu.ac.kr.

Lifetime Data Analysis
|February 9, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to reduce bias in analyzing semi-competing risks data, improving statistical accuracy for correlated event times in medical research.

Keywords:
Frailty modelsHierarchical likelihoodMarginal likelihoodModified likelihoodSemi-competing risks

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

583

Related Experiment Videos

Last Updated: Jan 29, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Frailty Assessment in an Aging Mouse Model
06:58

Frailty Assessment in an Aging Mouse Model

Published on: September 23, 2025

583

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Medical Data Analysis

Background:

  • Semi-competing risks data, common in medical studies, involves events where one type can prevent the other from occurring.
  • Observed event times in these scenarios can be correlated, posing analytical challenges.
  • Existing frailty models for semi-competing risks data may suffer from significant bias in finite samples.

Purpose of the Study:

  • To propose and validate modifications to reduce bias in frailty models for semi-competing risks data.
  • To explore the relationship between marginal and hierarchical likelihood approaches in this context.
  • To provide a more accurate statistical framework for analyzing correlated event times.

Main Methods:

  • Development of bias-reduced estimators using the hierarchical likelihood.
  • Investigation of the theoretical links between marginal and hierarchical likelihood.
  • Conducting simulation studies to assess the performance of the proposed modifications.

Main Results:

  • The proposed modifications effectively reduce the bias observed in standard maximum likelihood estimators for semi-competing risks data.
  • Simulation results demonstrate the superior performance and accuracy of the hierarchical likelihood approach.
  • The study clarifies the interplay between marginal and hierarchical likelihood methodologies.

Conclusions:

  • The hierarchical likelihood offers a robust solution for analyzing semi-competing risks data, mitigating finite sample bias.
  • The proposed method provides a valuable tool for researchers dealing with correlated event time data, as demonstrated in the breast cancer study example.
  • This work enhances the statistical rigor for survival analysis in complex medical research settings.